Cardiovascular Diseases Research in Pennsylvania 3rd District (PA-03)
CFDA 93.837 and Pennsylvania 3rd District (PA-03) meet at $572,405,758.79 in USAspending.gov obligations, spread across 258 awards. Two hundred fifty-eight research awards equal about 5.1% of PA-03’s $11,205,842,981.38 district obligation total — a mid-volume NHLBI-style cell whose row count is high relative to the dollar book. That pair is Cardiovascular Diseases Research and Pennsylvania 3rd District (PA-03) — not Pennsylvania’s entire federal inflow, not Cardiovascular Diseases Research nationwide, and not cash already paid. Implied average obligation is about $2,218,626.97 ($572,405,758.79 ÷ 258). Correlation is not causation.
Key figures
- Cardiovascular Diseases Research in Pennsylvania 3rd District (PA-03): $572,405,758.79 across 258 awards.
- About 5.1% of the district’s $11,205,842,981.38 all-program obligation total.
- Implied mean about $2,218,626.97 per record (ratio only).
- CFDA 93.837 × PA-03 is an obligation join, not a lab roster or trial census.
- Figures are USAspending obligations, not outlays.
Reading CFDA 93.837 inside PA-03
CFDA 93.837 and congressional district PA-03 meet here. $572,405,758.79 is the USAspending.gov obligation sum on awards that carry both tags. It is not Cardiovascular Diseases Research’s nationwide total, not every federal dollar coded to Pennsylvania 3rd District (PA-03), and not an outlay register. The packet does not split heart-failure from atherosclerosis projects, and it does not name labs. 258 is an action count: modifications and repeat awards add rows. Unique recipients are unpublished. It is not a clinic census, a trial-enrollment file, or a named-principal-investigator roster.
This page reports cardiovascular-diseases research assistance USAspending tagged to this district. The headline $572,405,758.79 sits beside a district-wide obligation total of $11,205,842,981.38; the 5.1% share is arithmetic on those two packet facts, not a ranking of Pennsylvania districts as winners or losers. Obligations are not outlays. Do not treat PA-03’s 93.837 cell as Pennsylvania statewide NIH. The state hub is a parent. Open Pennsylvania 3rd District for the district table without this program filter, CFDA 93.837 for the program without the PA-03 filter, Pennsylvania federal spending for the state extract, and All spending ties for other pairs.
Catalog line 93.837 without inventing a disease pie
USAspending labels CFDA 93.837 as CARDIOVASCULAR DISEASES RESEARCH. That catalog number produced $572,405,758.79 when crossed with Pennsylvania 3rd District (PA-03) place of performance. The program hub does not require PA-03 geography. The district hub does not require Cardiovascular Diseases Research. Only this tie applies both filters, which is why it cites 258 awards. The packet does not split heart-failure from atherosclerosis projects, and it does not name labs.
Correlation is not causation: Pennsylvania 3rd District (PA-03) did not cause $572,405,758.79 by existing as a large or small place, and research employment figures are not packet facts. The join is 93.837 × PA-03 only. It is not a clinic census, a trial-enrollment file, or a named-principal-investigator roster. Do not invent contractors or award recipients to fill the gap. Campaign donations on FEC tables do not fund this USAspending cell; the datasets are separate.
How Pennsylvania geography is coded on this join
Pennsylvania 3rd District (PA-03) on this join is a USAspending geography field, not a claim that every dollar was disbursed to residents of that district. Awards can list PA-03 while later work occurs elsewhere. Awards tagged to other Pennsylvania districts belong on those ties even when the CFDA is also 93.837. Pennsylvania 3rd District (PA-03) is a numbered congressional place-of-performance code inside Pennsylvania. Other Pennsylvania districts keep their own 93.837 cells.
Pennsylvania federal spending shows how CFDA 93.837 sits beside other programs in the same state extract. $572,405,758.79 is one district-program column, not the state table. This packet does not split Pennsylvania 3rd District (PA-03) by county, city, or census tract. Awards that carry a different CFDA stay on those other ties even if the work sounds related to Cardiovascular Diseases Research. The district-wide obligation total published here is $11,205,842,981.38; $572,405,758.79 is the Cardiovascular Diseases Research slice of that denominator.
USAspending obligations on this pair
USAspending.gov records an obligation when the federal government commits funds on an award. $572,405,758.79 is that kind of sum for Cardiovascular Diseases Research inside PA-03 coding. Later deobligations, recoveries, or payment schedules can change what leaves the Treasury without this join rewriting itself into a cash register. This packet does not split assistance from contracts. Treating $572,405,758.79 as research already performed confuses obligation with outlay.
Pennsylvania’s own budget is a separate ledger. Mixing it with the 258-row cardiovascular cell leaves USAspending.gov. Treat 258 as award records in the aggregate, not unique vendors and not patients, trials, or labs. Do not annualize without a year field in the packet. The implied mean (about $2,218,626.97) is a concentration statistic, not a published cost per grant and not a typical NHLBI award. The 5.1% share describes this join, not a ranking of Pennsylvania districts.
Citing $572,405,758.79 without dropping a join side
Cite USAspending.gov: Cardiovascular Diseases Research (CFDA 93.837) obligated $572,405,758.79 on 258 awards coded to Pennsylvania 3rd District (PA-03). Name Cardiovascular Diseases Research and Pennsylvania 3rd District (PA-03) together. Keep the obligation word. If Pennsylvania 3rd District or CFDA 93.837 has refreshed, prefer the live hub over this snapshot for current rows. The pair is not a clinic census, a trial-enrollment file, or a named-principal-investigator roster. 5.1% of $11,205,842,981.38 is the district share on this packet, not a performance score.
Row count versus dollar concentration
Two hundred fifty-eight awards against a $572.4 million cardiovascular cell is a thicker file than a three-row formula grant. A large row count makes a disease-component pie tempting; the packet still does not supply one. A large row count also makes a named-lab story tempting; the packet still does not name investigators. The implied mean (about $2,218,626.97) and the district share (about 5.1% of $11,205,842,981.38) are ratios of packet facts. Prefer Pennsylvania 3rd District and CFDA 93.837 if the live tables moved.
Questions
- How much Cardiovascular Diseases Research spending is coded to Pennsylvania 3rd District (PA-03)?
- USAspending.gov lists $572,405,758.79 in Cardiovascular Diseases Research obligations across 258 awards with place of performance in Pennsylvania 3rd District (PA-03). CFDA 93.837 × PA-03 is an obligation join, not an outlay and not Pennsylvania’s complete federal ledger. The cell is about 5.1% of the district’s published total ($11,205,842,981.38).
- Do 258 awards mean 258 labs or trials in PA-03?
- No. Award count is a row count of USAspending actions and can include continuations and modifications. It is not a count of labs, trials, or investigators. Unique recipients are unpublished. Average obligation is about $2,218,626.97, a ratio of those two facts only.
- Is $572,405,758.79 cash already paid in Pennsylvania 3rd District (PA-03)?
- No. Obligations are commitments recorded on USAspending.gov awards. Outlays are a different concept and are not this packet’s headline. Treating $572,405,758.79 as research already performed confuses those terms.
- Where are the live PA-03 and CFDA 93.837 tables?
- Pennsylvania 3rd District is the district parent. CFDA 93.837 is the program hub. Pennsylvania federal spending is the Pennsylvania parent. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes 93.837 × PA-03 at $572,405,758.79.
USAspending.gov congressional district place-of-performance joined to CFDA program. Obligations are not outlays.